We reviewed outlooks from a dozen bulge-bracket banks, asset managers, and global investment firms to identify the most useful takeaways for active investors like you.
Dec 27, 2025
Sep 26, 2026
•
1 min read
Plus, a precision medicine company betting on human genetics....
Sep 19, 2026
Plus, a Top 1% analyst's Street-high edge-AI call...
Sep 12, 2026
Plus, the largest US gas producer at a peer discount...